NANOVALENT PHARMACEUTICALS INC

Advancing the Power of Targeted Therapies with nADCs

Bozeman, United States · Founded 2016 · $4.0M raised

Headquarters
Bozeman, Montana
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$4.0M
Last Round
$4.0M Grant
Rounds
1

About

NanoValent Pharmaceuticals develops novel nano-ADC-like Targeted Nanospheres (nADC/TNS) using a proprietary Hybrid Polymerized Liposomal Nanoparticle (HPLN) platform to deliver targeted cancer therapies with superior selectivity and reduced toxicity. Lead product NV103/NV105 is approaching IND status for glioblastoma, ovarian cancer, pancreatic cancer, and Ewing sarcoma.

Summary

NANOVALENT PHARMACEUTICALS INC is a Biotech company based in Bozeman, United States, founded in 2016. It has raised $4.0M in total across 1 round. Investors include National Institutes of Health.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

$4.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NANOVALENT PHARMACEUTICALS INC on Indexed.vc
<a href="https://indexed.vc/companies/nanovalent-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/nanovalent-pharmaceuticals-inc" alt="NANOVALENT PHARMACEUTICALS INC on Indexed.vc" width="260" height="76" /></a>